Podcasts / Making sense of pTau 181: A GP guide to the new dementia blood test
Save


0.5 hours
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
0.5 hours
These are activities that require reflection on feedback about your work.
1 hours
These are activities that use your work data to ensure quality results.
Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.
Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.
Discover how the pTau 181 plasma test, the first FDA-cleared blood biomarker, is changing the way GPs approach dementia assessment. Join Prof Amy Brodtmann and Dr Marita Long as they discuss when this test can meaningfully guide diagnosis and next steps.
In this episode:
Experts: Prof Amy Brodtmann, Cognitive Neurologist
Host: Dr Marita Long, GP & Medical Educator
Total time: 28 mins
Recommended resources:

Rosacea – Smarter Diagnosis and State-of-the-Art Care

The Role of SGLT2 Inhibitors in Preventing Dialysis

Syphilis is on the Rise – What GPs Can do to Turn it Around

COPD Cases

expert
Cognitive Neurologist, Monash University; Cognitive Neurology Lead, Eastern Cognitive Disorders Clinic, Cognitive Neurology Lead, Melbourne Health Cognitive Neurology Service


Browse the latest podcasts from Healthed.
You have completed the Educational Activities (EA) component of this activity.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.
